TD Cowen Keeps Their Buy Rating on Metlife (MET)
In a report released today, Andrew Kligerman from TD Cowen maintained a Buy rating on Metlife, with a price target of $87.00.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to TipRanks, Kligerman is a 5-star analyst with an average return of 8.9% and a 63.39% success rate. Kligerman covers the Financial sector, focusing on stocks such as Metlife, Allstate, and Neptune Insurance Holdings, Inc. Class A.
In addition to TD Cowen, Metlife also received a Buy from Barclays’s Alex Scott in a report issued today. However, on the same day, Piper Sandler maintained a Hold rating on Metlife (NYSE: MET).
Based on Metlife’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $23.81 billion and a net profit of $809 million. In comparison, last year the company earned a revenue of $18.44 billion and had a net profit of $1.27 billion
Read More on MET:
Disclaimer & DisclosureReport an Issue
- MetLife price target raised to $93 from $89 at Barclays
- MetLife reports Q1 adjusted EPS $2.42, consensus $2.27
- MetLife Reports Strong First-Quarter 2026 Financial Performance
- MET Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Sun Life Financial to pay $213.5M settlement in class action lawsuit
